Effects of hexafluoroisopropanol on sevoflurane anesthesia and recovery quality in elderly patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050847

Enrollment

Unknown

Registered

2021-09-05

Start date

2021-08-24

Completion date

Unknown

Last updated

2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic surgery

Interventions

Group 1:Sevoflurane 0.5MAC inhaled

Group 2:Sevoflurane 1MAC inhaled

Group 3:Sevoflurane 1.5MAC inhaled

Eligibility

Sex/Gender

All

Age

65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 65 to 90 years; 2. ASA I-III, laparoscopic surgery, and the estimated operation time is 2.5-6 hours.

Exclusion criteria

Exclusion criteria: 1. Abnormal liver and kidney function; 2. Received drugs affecting liver metabolic function within two weeks; 3. History of alcohol and drug abuse; 4. Mental disorders.

Design outcomes

Primary

Measure	Time frame
The concentration of Hexafluoroisopropanol;	—

Countries

China

Contacts

Public ContactYang Xiaolin

Affiliated Hospital of North Sichuan Medical College

879921874@qq.com+86 13990826183

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026